Evaluation of the Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal Atrial Fibrillation
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 250 participants.
Also called NCT07714876
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 250 participants
- Sponsor
- Registry
-
NCT07714876
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07714876. Allocation not applicable; no masking; primary purpose treatment. Start 2026-12 (anticipated); primary completion 2029-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of the Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal Atrial Fibrillation
- Acronym
- PULSAR PAS
- Condition
- Paroxysmal Atrial Fibrillation
- Intervention (Device)
- Globe Pulsed Field System
- Lead sponsor
- Kardium Inc.
Record details
- Record id
cardio:ct-nct07714876- Content hash
a8500c071f939cb7ce20a61b406fc4a0523ace620dbcedb09cbaf03cc70eba91